Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.
Perez CA, Pajak TF, Rubin P, Simpson JR, Mohiuddin M, Brady LW, Perez-Tamayo R, Rotman M. Perez CA, et al. Among authors: rotman m. Cancer. 1987 Jun 1;59(11):1874-81. doi: 10.1002/1097-0142(19870601)59:11<1874::aid-cncr2820591106>3.0.co;2-z. Cancer. 1987. PMID: 3032394 Clinical Trial.
Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: report by the Radiation Therapy Oncology Group.
Perez CA, Stanley K, Grundy G, Hanson W, Rubin P, Kramer S, Brady LW, Marks JE, Perez-Tamayo R, Brown GS, Concannon JP, Rotman M. Perez CA, et al. Among authors: rotman m. Cancer. 1982 Sep 15;50(6):1091-9. doi: 10.1002/1097-0142(19820915)50:6<1091::aid-cncr2820500612>3.0.co;2-0. Cancer. 1982. PMID: 6286087 No abstract available.
A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group.
Perez CA, Stanley K, Rubin P, Kramer S, Brady L, Perez-Tamayo R, Brown GS, Concannon J, Rotman M, Seydel HG. Perez CA, et al. Among authors: rotman m. Cancer. 1980 Jun 1;45(11):2744-53. doi: 10.1002/1097-0142(19800601)45:11<2744::aid-cncr2820451108>3.0.co;2-u. Cancer. 1980. PMID: 6991092 Clinical Trial. No abstract available.
Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28.
Epstein BE, Scott CB, Sause WT, Rotman M, Sneed PK, Janjan NA, Davis LW, Selim H, Mohiuddin M, Wasserman TH, et al. Epstein BE, et al. Among authors: rotman m. Cancer. 1993 Feb 15;71(4):1362-7. doi: 10.1002/1097-0142(19930215)71:4<1362::aid-cncr2820710431>3.0.co;2-5. Cancer. 1993. PMID: 8435812 Clinical Trial.
255 results